A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)-Reference-Cited by-同舟云学术

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)

Published:2001-07 Issue:2 Volume:85 Page:141-146
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Riccardi A,Pugliese P,Danova M,Brugnatelli S,Grasso D,Giordano M,Bernardo G,Giardina G,Fava S,Montanari G,Pedrotti C,Trotti G,Rinaldi E,Poli M A,Tinelli C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference26 articles.

1. Do oncologists have an increasing interest in the quality of life of their patients? A literature review of the last 15 years

2. The bigger the better? … or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer

3. Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer

4. Comparison of CMF (Cyclophosphamide, Methotrexate, and 5-Fluorouracil) With a Rotational Crossing and a Sequential Intensification Regimen in Advanced Breast Cancer

5. Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flavonoids: A Reservoir of Drugs from Nature;Mini-Reviews in Medicinal Chemistry;2023-04

2. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis;Pharmaceuticals;2023-03-30

3. Impact of chemotherapy schedule modification on breast cancer patients: a single-centre retrospective study;International Journal of Clinical Pharmacy;2020-03-17

4. Taxane-induced arthralgia and myalgia: A literature review;Journal of Oncology Pharmacy Practice;2016-06-23

5. Weekly Docetaxel and Gemcitabine following Docetaxel plus Epirubicin or Vinorelbine as First-Line Treatment of Metastatic Breast Cancer: Results of a Multicenter Phase II Study;Tumori Journal;2006-01